TipRanks on MSN

ACADIA Pharmaceuticals Advances Phase 2 Study of ACP-204 for Lewy Body Dementia Psychosis

ACADIA Pharmaceuticals Inc. (($ACAD)) announced an update on their ongoing clinical study. Study Overview: ACADIA Pharmaceuticals Inc. is ...
TipRanks on MSN

ACADIA Pharmaceuticals Advances Phase 3 Study for Lewy Body Dementia Psychosis Treatment

ACADIA Pharmaceuticals Inc. (($ACAD)) announced an update on their ongoing clinical study. ACADIA Pharmaceuticals Inc. is conducting a Phase 3, ...